Tumor‐associated splicing events correlated with worse survival (hazard ratios 1.5 to 2.17, p‐values 2.54e‐4 to 0.0349) implying that SRSF3‐dependent splicing activity is associated with better survival (Figure 8b and Figure S8c–e, Supporting Information). The gene discussed is SRSF3; the disease is neoplasm.